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Abstract
Objective: To prospectively explore the impact of obstructive sleep apnea 
(OSA) on conventional Doppler indices and to identify possible negative 
prognostic factors for left ventricular diastolic dysfunction.
Materials and Methods: All included subjects had overnight polysomnog-
raphy. All subjects underwent a comprehensive echocardiography exami-
nation to evaluate systolic and diastolic function of the left ventricle. A 
multiple logistic regression model was created to identify potential negative 
prognostic factors for left ventricular dysfunction.
Results: A significant decrease in the ratio of early and atrial mitral flow 
velocity (E/A ratio) in OSA patients was found. Patients with moderate-to-
severe OSA had a significant increase in the odds ratio for development of 
an abnormal E/A ratio (p = 0.014, multivariate logistic regression). There was 
a significant negative correlation between E/A ratio and apnea-hypopnea 
index (p = 0.01). Non-obese OSA patients and obese-OSA patients carried 
significantly increased odds ratios for the development of a reduced E/A 
ratio (p = 0.02 and 0.038, respectively).
Conclusion: Subjects with OSA had reduced mitral E/A ratios, which 
implies possible impaired diastolic heart function. Further study to reverse 
impaired diastolic function via lifestyle modifications and treatment with 
nasal continuous positive airway pressure or surgery is warranted. [Tzu Chi 
Med J 2009;21(3):210–217]
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1. Introduction
Obstructive sleep apnea (OSA) is characterized by 
repetitive collapse of the upper airway and hypoxemia 
during sleep. Prevalence reports show that 4% of 
men and 2% of women are affected by OSA [1]. OSA 
may result in many complications and morbidities. 
Cardiac arrhythmias, heart failure, impaired neuro-
psychological ability, and an increased incidence of 
stroke are closely correlated with OSA [2–4]. Cardio-
vascular disorders are the most important complica-
tions associated with OSA, resulting in severe morbidity 
and mortality. Normally, central sympathetic activity, 
heart rate, blood pressure, and cardiac output are 
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reduced during sleep [5]. However, recurrent hypoxia 
during sleep in OSA patients disrupts the normal 
sleep cycle and permits surges in blood pressure 
and heart rate. OSA may contribute to the formation 
of left ventricular hypertrophy, and severe and mod-
erate OSA results in an increased ventricular mass 
and left ventricular global dysfunction [6]. Chronic 
inflammation may be a result of repetitive hypox-
emia in OSA patients and may be involved in the 
development of atherosclerosis and cardiovascular 
disorders [7].
Diastolic heart failure causes 38–54% of all cases of 
heart failure [8]. Structural, functional, molecular, and 
mechanical dysfunction contributes to the formation 
of diastolic heart failure. Enlarged cardiomyocyte di-
ameter, abnormal titin function, abnormal matrix 
degradation and increased matrix metalloproteinase-9 
are involved in the pathogenesis of cardiovascular 
diseases [8–10]. These factors increase diastolic re-
sistance and stiffness of the left ventricle. During 
OSA, exaggerated negative intrathoracic pressure—
due to the futile inspiratory effect during upper airway 
obstruction—leads to an increase in left ventricular 
transmural pressure, development of cardiac myocyte 
slippage, adverse ventricular remodeling, and an 
increase in isovolumic relaxation time [11]. Further-
more, sleep apnea is associated with echocardio-
graphic evidence of increased left ventricular mass 
and impaired systolic function [12].
Early identification and appropriate treatment of 
left ventricular diastolic dysfunction is essential to 
prevent progression to heart failure and death in pa-
tients with OSA. Therefore, the purpose of this study 
was to explore the impact of OSA on left ventricular 
function and to identify negative prognostic factors 
for left ventricular dysfunction.
2. Materials and methods
2.1. Subjects
Thirty-five patients with OSA with an apnea-hypopnea 
index (AHI) ≥ 5 hours−1, and excessive daytime sleep-
iness (Epworth sleepiness scale > 10), and no current 
drug or mechanical treatment for OSA, were recruited 
for this study. Patients diagnosed with cancer, angina 
pectoris, atrial fibrillation, diabetes, chronic renal and/
or hepatic disease, chronic pulmonary disease, left 
ventricular dysfunction (left ventricular ejection frac-
tion < 55%) or serum electrolyte imbalances were ex-
cluded from the study. Fifteen healthy subjects, who 
were asymptomatic and underwent a sleep polysom-
nography for health promotion and disease prevention 
during annual health checkups, were recruited as 
control subjects. The criteria used to define normal 
sleep for this control group were an AHI < 5 hours−1 
and no daytime hypersomnolence (Epworth sleepiness 
scale < 10). The study was approved by the Ethics 
Committee of the hospital. All subjects provided in-
formed written consent prior to participation.
2.2. Protocol
Peripheral blood samples were drawn from the an-
tecubital vein between 6:00 and 7:00 AM after an 
overnight fast exceeding 8 hours. Serum cholesterol, 
triglyceride, high-density lipoprotein-cholesterol 
(HDL-C), low-density lipoprotein-cholesterol (LDL-C), 
glucose, and uric acid levels were measured. A gen-
eral physical examination was performed in all study 
participants. In addition, a full evaluation of the status 
of the upper airway was performed via nasopharyn-
golaryngoscopy. This included recording the palatal 
position and tonsil size. Weight and height were meas-
ured to calculate the body mass index (BMI). Blood 
pressure and heart rate were measured in a sitting 
position with the arm at heart level after 10 minutes 
of rest. Hypertension was defined as a blood pres-
sure ≥ 140/90 mmHg or current treatment with anti-
hypertensive medication. All study subjects with 
hypertension were on regular medication. Impaired 
glucose tolerance was established on the basis of a 
previous diagnosis of diabetes mellitus and treat-
ment with diet therapy/antidiabetic medications, or 
based on the results of two random fasting glucose 
levels that exceeded 126 mg/dL.
2.3. Polysomnography
All subjects with suspected OSA and all control sub-
jects participated in a sleep study consisting of a 
one-night portable polysomnography (M-10, Embletta 
device; Embla, Broomfield, CO, USA), which included 
a nasal pressure detector consisting of a nasal cannula 
and pressure transducer system, thoracoabdominal 
movement detection through two piezoelectric belts, 
a finger pulse oximeter, and body position detector. 
Patient with a sleep duration less than 6 hours were 
excluded.
Apnea episodes were defined as complete cessa-
tion of oronasal airflow for ≥ 10 seconds and hypopnea 
as a > 50% reduction in oronasal airflow accompa-
nied by a > 4% decrease in oxygen saturation meas-
ured via pulse oximeter. The oxygen desaturation index 
was defined as the number of oxygen desaturation 
events per hour of sleep. Subjects with an AHI ≥ 5 
were diagnosed with OSA. On the basis of this test 
result, the study patients diagnosed with OSA were 
divided into two groups: those with mild OSA 
(AHI = 5–20) and those with moderate to severe OSA 
(AHI > 20).
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2.4. Echocardiographic analysis
M-mode, two dimensional, Doppler echocardiography 
(VIVID 3; GE Medical Systems, Milwaukee, WI, USA) 
was performed with a 2.5 MHz probe with the sub-
jects in the left lateral decubitus position. The ultra-
sonographer was blinded to the diagnosis of OSA in 
all subjects. Left ventricular dimensions during dias-
tole, systole, and left atrial diameters during diastole 
were measured by the M-mode technique. This was 
conducted in the parasternal long axis view while di-
mensions of the right ventricle were measured in the 
apical four-chamber view. The left ventricular ejection 
fraction was calculated by the modified Simpson’s 
method using the following equation: (diastolic 
volume − systolic volume)/diastolic volume.
A truncated ellipsoid method was employed to 
measure the left ventricular (LV) mass in the apical 
four-chamber view calculated at the end-diastolic 
phase. The LV mass index was obtained by the fol-
lowing equation: LV mass/body surface area early (E) 
and atrial (A) transmitral maximal flow velocities; the 
E/A ratio was assessed using a pulse wave Doppler 
technique taken in the apical four-chamber view 
with a sample volume between the mitral leaflet tip 
during diastole. The isovolumic relation time (IVRT) 
was measured using a continuous wave Doppler 
technique. If tricuspid regurgitation was detected by 
color Doppler echocardiography, the trans-tricuspid 
pressure gradient was measured using continuous 
wave Doppler. Abnormal systolic function was defined 
as an ejection fraction < 55%; abnormal diastolic 
function was defined as an E/A ratio < 1 and/or 
IVRT > 100 ms. The definition of diastolic heart failure 
requires the presence of signs or symptoms of heart 
failure, normal or mildly abnormal systolic left ven-
tricular function, and evidence of diastolic left ven-
tricular dysfunction. Diagnostic evidence of diastolic 
left ventricular dysfunction can be obtained by inva-
sive hemodynamic measurements or noninvasive 
tissue Doppler examination. This was outlined in a 
recent consensus statement on the diagnosis of di-
astolic dysfunction by the Heart Failure and Echo-
cardiography Associations of the European Society 
of Cardiology [13].
2.5. Statistical analysis
Statistical analysis was performed using SPSS version 
12 (SPSS Inc., Chicago, IL, USA). Values are expressed 
as mean ± standard deviation or percentages. Dif-
ferences between groups were examined by the 
Kruskal-Wallis test. The Mann-Whitney U test was 
used for pairwise group comparisons. The correla-
tion between two continuous variables was analyzed 
with Spearman’s correlation coefficient. Pearson’s 
χ2 test was used to compare proportional data, and 
multiple logistic regression was used to control for 
age, sex, and hypertension.
3. Results
The final study sample consisted of 51 subjects, 16 
controls, and 35 OSA patients. Basic characteristics 
of the patients are shown in Table 1. There were no 
significant differences in their age, sex, smoking 
history, history of glucose intolerance, systolic blood 
pressure, or heart rate. The BMI was much higher in 
Table 1 — Characteristics and laboratory data in patients with mild, moderate and severe OSA
 Control Mild OSA Moderate-to-severe OSA 
p
 (n = 16) (n = 20) (n = 15)
Age (yr) 39 ± 7.8 45 ± 9.5 46 ± 11.9 NS
Sex (male, %) 82 85 100 NS
BMI (kg/m2) 27 ± 3.8 28 ± 3.3 31 ± 5.1*‡ 0.011
AHI per hr 2 ± 1.6 11 ± 4.5 48 ± 21†§ < 0.001
ODI per hr 4 ± 3.8 14 ± 7.3 45 ± 21.1 < 0.001
Smoking history (%) 44 45  33 NS
Glucose intolerance (%)  6 15  7 NS
Hypertension (%) 19 10  53 0.011
Glucose (mg/dL) 102 ± 27 100 ± 11.4 107 ± 64 NS
Uric acid (mg/dL) 6 ± 1.8 6 ± 1.5 7 ± 1.4 NS
Triglyceride (mg/dL) 179 ± 116 195 ± 102.6 212 ± 149.5 NS
Total cholesterol (mg/dL)  173 ± 57.4 198 ± 40.5 189 ± 46.3 NS
HDL-C (mg/dL) 43 ± 8.6 42 ± 7.8 41 ± 13.8 NS
LDL-C (mg/dL) 125 ± 34.3 133 ± 38.8 124 ± 42.3 NS
SBP (mmHg) 125 ± 21.4 123 ± 14.3 132 ± 16.8 NS
DBP (mmHg) 71 ± 10.2 75 ± 10.5 82 ± 11.8* 0.032
HR (pulse per min) 79 ± 10.7 75 ± 10.5 73 ± 10.1 NS
*p < 0.05 and †p < 0.01 versus control; ‡p < 0.05 and §p < 0.01 versus mild OSA. OSA = obstructive sleep apnea syndrome; NS = not significant; 
BMI = body mass index; AHI = apnea-hypopnea index; ODI = oxygen desaturation index; HDL-C = high-density lipoprotein-cholesterol; LDL-C = low-
density lipoprotein-cholesterol; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate.
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patients with moderate-to-severe OSA than the con-
trol subjects, or patients with mild OSA (p = 0.01). 
Diastolic blood pressure was higher in patients with 
moderate-to-severe OSA than the control subjects 
(p = 0.032), and the percentage of those with a history 
of hypertension was much higher in the moderate-
to-severe OSA group (p = 0.011). The fasting serum 
levels of glucose, uric acid, triglycerides, total choles-
terol, HDL-C, and LDL-C were not statistically differ-
ent among the three groups. As shown in Table 2, 
left ventricular systolic function was not significantly 
different between the subjects; however, the E/A 
ratio was significantly lower in subjects with moderate-
to-severe OSA (p = 0.017; Fig. 1A).
OSA patients were classified into two subgroups 
according to BMI: non-obese OSA (BMI < 27 kg/m2) 
and obese OSA (BMI ≥ 27 kg/m2). The E/A ratios in the 
non-obese OSA group were still significantly lower 
than those in the control subjects, although there 
was no difference in BMI between these two groups 
(p = 0.019; Fig. 1B; Table 3). Fig. 2 shows a negative 
correlation between E/A ratio and AHI (Spearman’s 
rank correlation coefficient = −0.36, p = 0.01), but there 
was no significant association between E/A ratio and 
BMI (p = 0.68). Fig. 3 shows that 38% of the moderate-
to-severe OSA patients, 27% of the non-obese OSA 
patients, and 29% of the obese OSA patients had 
reduced E/A ratios and prolonged IVRTs. There was 
Table 2 — Left ventricular function by echocardiography in patients with sleep apnea
 Control Mild OSA Moderate-to-severe OSA 
p
 (n = 16) (n = 20) (n = 15)
Left atrium (mm) 37 ± 5 37 ± 6.3 38 ± 6.7 NS
IVSD (mm) 9 ± 1.5 9 ± 1.6 10 ± 1.7 NS
LVEDD (mm) 49 ± 4.1 49 ± 4.2 50 ± 2.6 NS
LVESD (mm) 28 ± 3.7 29 ± 2.4 30 ± 3.5 NS
Parameters of systolic function    
 Ejection fraction (55–75%) 70 ± 5 70 ± 7.2 69 ± 5.4 NS
Parameters of diastolic function    
 E/A ratio 1.3 ± 0.34 1.1 ± 0.36 0.99 ± 0.25* 0.017
 IVRT (msec) 90 ± 21.1 99 ± 14.9 96 ± 16.9 NS
Left ventricular mass    
 LVM (g) 149 ± 40.9 173 ± 40.4 177 ± 49.8 NS
 LVMI (g/m2) 78 ± 19 91 ± 17.7 86 ± 23.7 NS
*p < 0.05 versus control. OSA = obstructive sleep apnea syndrome; IVSD = interventricular septum thickness; LVEDD = left ventricular end-diastolic 
diameter; LVESD = left ventricular end-systolic diameter; E/A ratio = ratio of early and atrial mitral flow velocity; IVRT = isovolumic relaxation time; 
LVM = left ventricular mass; LVMI = LVM index; NS = not significant.
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Fig. 1 — (A) Correlation between the ratio of early and atrial mitral flow (E/A ratio) and severity of obstructive sleep 
apnea (OSA). (B) Cardiac measurement in the control subjects, non-obese OSA, and obese OSA groups. The E/A ratio 
was significantly decreased in the non-obese OSA group (p = 0.032) and borderline decreased in the obese OSA group 
(p = 0.078 vs. control group).
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a significant association between a decreased E/A 
ratio and prolonged IVRT with severity of OSA (p = 
0.043; Fig. 3). Table 4 shows that the moderate-to-
severe OSA group had a significantly increased odds 
ratio for the development of a decreased E/A ratio 
(p = 0.036) after adjusting for age, sex, and hyperten-
sion. The non-obese OSA group and obese OSA group 
had significantly increased risks of developing reduced 
E/A ratios (p = 0.02 and 0.038, respectively).
4. Discussion
This study revealed that individuals with moderate-
to-severe OSA have decreased E/A ratios—this 
impairment may be related to repetitive obstructive 
apnea events during sleep. However, a close correla-
tion between BMI and AHI was observed. It is possi-
ble that the decreased E/A ratio and increased IVRT 
may be attributed to obesity, rather than repetitive 
hypoxia. For this reason, the patients with OSA were 
divided into non-obese and obese OSA groups. The 
E/A ratios in the non-obese OSA group were still sig-
nificantly lower than those in control subjects, al-
though there was no significant difference in their 
BMI. Our results also revealed that there was a sig-
nificant negative correlation between E/A ratio and 
AHI, but not between E/A ratio and BMI. This finding 
suggests that some part of the E/A ratio is decreased 
independent of obesity. Multivariate logistic regression 
Table 3 — Left ventricular function by echocardiography in non-obese (BMI < 27 kg/m2) and obese (BMI ³ 27 kg/m2) 
OSA patients
 Control (n = 16) Non-obese OSA (n = 11) Obese OSA (n = 24) p
BMI (kg/m2) 27 ± 3.8 25 ± 1.2 31 ± 4.8†‡ < 0.001
AHI per hr 2 ± 1.6 20 ± 4* 30 ± 25† < 0.001
ODI per hr 4 ± 3.8 18 ± 12.2* 31 ± 23† < 0.001
Parameters of systolic function    
 Ejection fraction (55–75%) 70 ± 1.4 69 ± 2.2 69 ± 1.8 NS
Parameters of diastolic function    
 E/A ratio  1.3 ± 0.34 0.99 ± 0.31* 1 ± 0.32 0.019
 IVRT (msec) 91 ± 3.6 98 ± 5.2 99 ± 4.8 NS
Left ventricular mass    
 LVM (g) 149 ± 40.9 164 ± 35.8 180 ± 47.4 NS
 LVMI (g/m2) 78 ± 19 92 ± 17.5 88 ± 21.4 NS
*p < 0.05 and †p < 0.01 versus control; ‡p < 0.01 versus mild OSA. BMI = body mass index; OSA = obstructive sleep apnea syndrome; AHI = apnea-
hypopnea index; ODI = oxygen desaturation index; E/A ratio = ratio of early and atrial mitral flow velocity; IVRT = isovolumic relaxation time; LVM = left 
ventricular mass; LVMI = LVM index; NS = not significant.
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Fig. 2 — (A) Correlation between the ratio of early and atrial mitral flow (E/A ratio) and apnea-hypopnea index 
(p = 0.011). (B) Correlation between the E/A ratio and body mass index (p  = 0.68). AHI = apnea-hypopnea index; BMI = body 
mass index.
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revealed that non-obese patients with OSA and obese 
OSA patients had significantly increased risks of 
developing decreased E/A ratios.
The definition of diastolic heart failure requires the 
presence of particular signs or symptoms. Although 
diagnostic evidence of diastolic left ventricular dys-
function can be obtained by invasive hemodynamic 
measurements or noninvasive tissue Doppler, tradi-
tional Doppler methods are still popular and widely 
used. Our findings in this series did not fulfill the cri-
teria of diastolic left ventricular dysfunction by defi-
nition, but echocardiographic abnormalities such as 
decreased E/A ratio were found in patients with sleep 
apnea.
Niroumand et al [14] reported that E/A ratio is 
significantly correlated with age, but not with AHI 
or SaO2 < 90%. However, Arias et al [15] suggested 
that diastolic dysfunction is only predicted by AHI in 
multiple logistic regression. Kim et al [16] reported 
that early diastolic velocity measured by tissue 
Doppler imaging was inversely correlated with AHI, 
and there was no significant association between 
AHI and either E/A ratio or IVRT. In our series, an 
abnormal E/A ratio was correlated with AHI (Fig. 2), 
and with the severity of OSA in multivariate logistic 
regression—after adjusting for age, sex, and hyper-
tension (Table 4).
OSA can induce a series of mechanical, hemody-
namic, chemical, neural, molecular, and inflamma-
tory reactions with adverse consequences for the 
cardiovascular system. Tazaki et al [10] reported that 
increased matrix metalloproteinase-9 was found in 
patients with OSA, and an excess of matrix metallopro-
teinase-9 may be responsible for structural degradation 
Reduced E/A ratio and prolonged IVRT
EA or IVRT within normal range E/A < 1 & IVRT > 100 ms
93.33%
6.67%
93.33%
6.67%
78.95%
21.05%
61.54%
38.46%
100
Pe
rc
en
t
80
60
40
20
0
Control Mild OSA Moderate-
to-severe OSA
72.73%
27.27%
71.43%
28.57%
100BA
Pe
rc
en
t
80
60
40
20
0
Control Non-obese OSA Obese OSA
Fig. 3 — Distribution of decreased ratio of early and atrial mitral flow (E/A ratio) and prolonged isovolumic relation 
time in (A) controls and patients with different severities of obstructive sleep apnea (OSA), and (B) controls and non-
obese OSA and obese OSA groups.
Table 4 — Multiple logistic regression analysis adjusted for age, sex, and hypertension
Variables
 E/A ratio < 1 IVRT > 100 ms
 OR (95% CI) p OR (95% CI) p
Sleep apnea classification
 Moderate-to-severe OSA 7.4 (1.1–48) 0.036 2 (0.3–11) 0.521
 Mild OSA 5.3 (0.8–32) 0.07 4 (0.7–19) 0.125
 Control group 1
Obesity & sleep apnea    
 Obese OSA 4 (1.02–28) 0.038 4.3 (0.7–15) 0.13
 Non-obese OSA 11 (1.4–84) 0.02 2 (0.3–11) 0.568
 Control group 1  1
E/A ratio = ratio of early and atrial mitral flow velocity; IVRT = isovolumic relaxation time; OR = odds ratio; CI = confidence interval; OSA = obstructive 
sleep apnea.
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and atherosclerosis. Exaggerated negative intratho-
racic pressure—due to the futile inspiratory effect dur-
ing upper airway obstruction—leads to an increase 
in left ventricular transmural pressure, development 
of cardiac myocyte slippage, adverse ventricular re-
modeling, and an increase in the isovolumic relaxa-
tion time [8,11,17]. Concurrently, enhanced negative 
intrathoracic pressure increases venous return to the 
right ventricle—this causes a left shift of the ventricu-
lar septum and impaired left ventricular diastolic fill-
ing [11,18]. Increased sympathetic nervous activity, 
which results from the interaction of several excita-
tory mechanisms, normally dormant during sleep, is 
a cardinal feature of OSA [5].
Nasal continuous positive airway pressure has 
been demonstrated to reverse abnormal E/A ratios 
in OSA patients with impaired diastolic function [15]. 
OSA patients with elevated inflammation markers—
such as tumor necrosis factor-α—treated with nasal 
continuous positive airway pressure, could experience 
decreases in inflammatory marker levels [7]. Together, 
these results imply that cardiac dysfunction and/or 
inflammation status is reversible in OSA patients 
and that these patients could benefit from treatment 
in order to reverse impaired heart function.
The main limitation of our study was the small 
number of subjects. In addition, we only used simple 
Doppler echocardiography to evaluate diastolic dys-
function instead of tissue Doppler echocardiography. 
Tissue Doppler echocardiography is a more sensitive 
tool for detecting diastolic dysfunction. Additional 
longitudinal studies are warranted to confirm our re-
sults. Nonetheless, this study did identify significant 
echocardiographic abnormalities in diastolic function 
in the moderate-to-severe OSA group.
In this study, no significant difference in systolic 
function among the three groups was found. However, 
a decreased E/A ratio was noted in the OSA group. 
Some part of the E/A ratio is decreased independent 
of obesity. Although a decreased E/A ratio was not 
enough to detect left ventricular diastolic dysfunc-
tion, it did offer some clue to diastolic dysfunction. 
Diastolic dysfunction is a major risk factor for the 
development of overt systolic heart failure. These re-
sults suggest that some part of impaired diastolic 
function develops early and deserves more attention 
in OSA patients.
In conclusion, this study revealed that increased 
severity of OSA may result in abnormal conventional 
Doppler indices. This may imply left ventricular diasto-
lic dysfunction. Diastolic dysfunction is a major risk 
for systolic heart failure and may be combined with 
systolic function. Individuals with moderate-to-severe 
OSA have impaired diastolic function and may there-
fore have an increased risk of overt heart failure. 
Impaired diastolic function develops early and de-
serves more attention in OSA patients.
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